Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Germ Cell Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01614132
What this trial is testing

Multicenter Pilot-study for the Therapy of Medulloblastoma of Adults

Who this might be right for
Medulloblastoma
University of Regensburg 33
Not applicableStudy completedNCT06168825
What this trial is testing

Mind Over Matter for Black and African American Women: A Single Arm Trial Examining Feasibility and Acceptability of a Supportive Intervention

Who this might be right for
CancerBreast CancerBrain Cancer+13 more
Inova Health Care Services 40
Testing effectiveness (Phase 2)Looking for participantsNCT04094610
What this trial is testing

Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Who this might be right for
Locally Advanced Solid TumorsMetastatic Solid TumorsLymphoma+1 more
Turning Point Therapeutics, Inc. 75
Not applicableLooking for participantsNCT05672043
What this trial is testing

Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China

Who this might be right for
MedulloblastomaCentral Nervous System Tumor, PediatricEpendymoma+3 more
Beijing Tiantan Hospital 400
Not applicableStudy completedNCT05131815
What this trial is testing

The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors

Who this might be right for
CancerCancer MetastaticNeoplasms+19 more
Cedars-Sinai Medical Center 8
Early research (Phase 1)Active Not RecruitingNCT06724926
What this trial is testing

Concurrent Azeliragon With Craniospinal Irradiation

Who this might be right for
Solid TumorHigh-grade GliomaLeptomeningeal Metastasis
NYU Langone Health 21
Not applicableEnded earlyNCT02039778
What this trial is testing

Stem Cell Radiotherapy and Temozolomide for Newly Diagnosed High-grade Glioma

Who this might be right for
GlioblastomaMalignant GliomaBrain Tumors+1 more
Beth Israel Medical Center 4
Early research (Phase 1)Study completedNCT00946335
What this trial is testing

ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Choroid Plexus Tumor+25 more
National Cancer Institute (NCI) 31
Large-scale testing (Phase 3)Study completedNCT00003916
What this trial is testing

Standard Radiation Therapy With or Without Stereotactic Radiation Therapy in Treating Patients With Glioma

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07708285
What this trial is testing

Luvometinib in Combination With Serplulimab for NF2-Related Tumors

Who this might be right for
NF2-related SchwannomatosisNF2Neurofibromatosis Type 2+2 more
Beijing Tiantan Hospital 30
Not applicableLooking for participantsNCT07631338
What this trial is testing

Low-grade Gliomas in Argentina: Incidence, Survival, and Therapeutic Strategies

Who this might be right for
Low-grade Glioma
Hospital Italiano de Buenos Aires 40
Testing effectiveness (Phase 2)Study completedNCT00335764
What this trial is testing

Sorafenib Combined With Erlotinib, Tipifarnib, or Temsirolimus in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+1 more
National Cancer Institute (NCI) 92
Testing effectiveness (Phase 2)Active Not RecruitingNCT04758533
What this trial is testing

Clinical Trial to Assess the Safety and Efficacy of AloCELYVIR With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG) in Combination With Radiotherapy or Medulloblastoma in Monotherapy

Who this might be right for
Diffuse Intrinsic Pontine GliomaMedulloblastoma, Childhood, Recurrent
Hospital Infantil Universitario Niño Jesús, Madrid, Spain 13
Testing effectiveness (Phase 2)Study completedNCT01285414
What this trial is testing

Verubulin, Radiation Therapy, and Temozolomide to Treat Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme
Myrexis Inc. 5
Early research (Phase 1)Study completedNCT01165333
What this trial is testing

Cilengitide in Combination With Irradiation in Children With Diffuse Intrinsic Pontine Glioma

Who this might be right for
Diffuse Intrinsic Pontine Glioma
Centre Oscar Lambret 32
Large-scale testing (Phase 3)Ended earlyNCT00031798
What this trial is testing

Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors

Who this might be right for
Brain and Central Nervous System TumorsCognitive/Functional EffectsDepression+2 more
Wake Forest University Health Sciences
Early research (Phase 1)Study completedNCT00390403
What this trial is testing

Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 50
Not applicableAvailableNCT05974410
What this trial is testing

Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients

Who this might be right for
GlioblastomaSquamous Cell CarcinomaHodgkin Lymphoma+14 more
AVM Biotechnology Inc
Testing effectiveness (Phase 2)Study completedNCT03027388
What this trial is testing

Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma

Who this might be right for
Astrocytoma, Grades II, III and IVGlioblastoma MultiformeGiant Cell Glioblastoma+2 more
National Cancer Institute (NCI) 7
Early research (Phase 1)Study completedNCT01421524
What this trial is testing

Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma

Who this might be right for
Multiple MyelomaLymphoma, Large B-Cell, DiffusePleiotropic Pathway Modifier+3 more
Celgene 271
Next Page